TRCT
EQ icon

Tower Research Capital (TRC)’s Equillium EQ Stock Holding History

Tower Research Capital (TRC)’s Portfolio EQ Stock Details EQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.58K Sell
1,291
-2,779
-68% -$4.57K ﹤0.01% 4453
2025
Q4 		$6.31K Sell
4,070
-2,336
-36% -$2.85K ﹤0.01% 4068
2025
Q3 		$9.16K Sell
6,406
-108
-2% -$114 ﹤0.01% 4036
2025
Q2 		$2.05K Sell
6,514
-305
-4% -$122 ﹤0.01% 4709
2025
Q1 		$2.67K Buy
6,819
+856
+14% +$638 ﹤0.01% 4518
2024
Q4 		$4.46K Buy
+5,963
New +$4.93K ﹤0.01% 4458
2024
Q2 		– Sell
-7,359
Closed -$17K – 5758
2024
Q1 		$17K Sell
7,359
-2,023
-22% -$3.52K ﹤0.01% 3143
2023
Q4 		$6.78K Sell
9,382
-510
-5% -$303 ﹤0.01% 4698
2023
Q3 		$7.32K Sell
9,892
-2,627
-21% -$2.11K ﹤0.01% 4480
2023
Q2 		$9.39K Buy
12,519
+9,074
+263% +$6K ﹤0.01% 4293
2023
Q1 		$3K Sell
3,445
-5,919
-63% -$5.66K ﹤0.01% 5186
2022
Q4 		$10K Buy
9,364
+616
+7% +$988 ﹤0.01% 3986
2022
Q3 		$19K Buy
8,748
+4,190
+92% +$10K ﹤0.01% 3973
2022
Q2 		$9K Sell
4,558
-1,036
-19% -$2.6K ﹤0.01% 4551
2022
Q1 		$18K Buy
5,594
+2,118
+61% +$7.75K ﹤0.01% 3621
2021
Q4 		$13K Buy
+3,476
New +$18.8K ﹤0.01% 4167
2021
Q3 		– Sell
-166
Closed -$1K – 5856
2021
Q2 		$1K Sell
166
-2,374
-93% -$15K ﹤0.01% 5198
2021
Q1 		$18K Sell
2,540
-3,968
-61% -$28.5K ﹤0.01% 3960
2020
Q4 		$35K Buy
+6,508
New +$34K ﹤0.01% 3447
2020
Q3 		– Sell
-3,777
Closed -$11K – 4886
2020
Q2 		$11K Sell
3,777
-97
-3% -$276 ﹤0.01% 3965
2020
Q1 		$10K Sell
3,874
-2,217
-36% -$9.54K ﹤0.01% 2017
2019
Q4 		$20K Buy
6,091
+5,834
+2,270% +$21.9K ﹤0.01% 1910
2019
Q3 		$1K Sell
257
-3,396
-93% -$14.6K ﹤0.01% 3846
2019
Q2 		$21K Buy
3,653
+1,236
+51% +$7.77K ﹤0.01% 2146
2019
Q1 		$19K Sell
2,417
-5,751
-70% -$47.4K ﹤0.01% 2292
2018
Q4 		$67K Buy
+8,168
New +$114K ﹤0.01% 1146

Other funds holding EQ

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Tower Research Capital (TRC)'s EQ Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Equillium (EQ) stake by 68% in Q1 2026, selling an estimated $4.57K and leaving 1,291 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #4453.

Tower Research Capital (TRC) first reported a position in EQ in Q4 2018 and has held it in 26 quarters since. The position peaked at $67K in Q4 2018. 50 funds tracked by Wall St. Rank hold EQ as of Q1 2026.

  • Tower Research Capital (TRC) held 1,291 shares of Equillium worth $2.58K as of Q1 2026.
  • Tower Research Capital (TRC) sold 2,779 Equillium shares in Q1 2026, an estimated $4.57K.
  • Equillium made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4453 holding.
  • Tower Research Capital (TRC) first reported a position in Equillium in Q4 2018 and has held it in 26 quarters since.
  • Tower Research Capital (TRC)'s Equillium position peaked at $67K in Q4 2018.
  • 50 funds tracked by Wall St. Rank held Equillium as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.